Works matching IS 02683369 AND DT 2004 AND VI 33 AND IP 8

Results: 21
    1
    2
    3

    Activity of single-agent melphalan 220-300?mg/m<sup>2</sup> with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.

    Published in:
    Bone Marrow Transplantation, 2004, v. 33, n. 8, p. 781, doi. 10.1038/sj.bmt.1704424
    By:
    • Meisenberg, B. R.;
    • Reece, D. E.;
    • Adams, V. R.;
    • Badros, A. Z.;
    • Brunner, J. L.;
    • Fenton, R. G.;
    • Filicko, J.;
    • Grosso, D. L.;
    • Hale, G. A.;
    • Howard, D. S.;
    • Johnson, V. P.;
    • Marshall, K. W.;
    • Mookerjee, B.;
    • Nath, R.;
    • Rapoport, A. P.;
    • Sarkodee-Adoo, C.;
    • Takebe, N.;
    • Vesole, D. H.;
    • Wagner, J. L.;
    • Phillips, G. L.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.

    Published in:
    Bone Marrow Transplantation, 2004, v. 33, n. 8, p. 815, doi. 10.1038/sj.bmt.1704444
    By:
    • Kreyenberg, H.;
    • Hoelle, W.;
    • Dueckers, G.;
    • Kremens, B.;
    • Dilloo, D.;
    • Sykora, K. -W.;
    • Niemeyer, C.;
    • Reinhardt, D.;
    • Vormoor, J.;
    • Gruhn, B.;
    • Lang, P.;
    • Greil, J.;
    • Handgretinger, R.;
    • Niethammer, D.;
    • Klingebiel, T.;
    • Beck, J. F.;
    • Bader, P.
    Publication type:
    Article
    19
    20
    21